Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prime Medicine (PRME) Assets Average (2022 - 2025)

Prime Medicine (PRME) has disclosed Assets Average for 4 consecutive years, with $363.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average rose 15.46% year-over-year to $363.9 million, compared with a TTM value of $363.9 million through Dec 2025, up 15.46%, and an annual FY2025 reading of $320.1 million, up 30.3% over the prior year.
  • Assets Average was $363.9 million for Q4 2025 at Prime Medicine, up from $332.0 million in the prior quarter.
  • Across five years, Assets Average topped out at $363.9 million in Q4 2025 and bottomed at $216.5 million in Q4 2023.
  • Average Assets Average over 4 years is $297.2 million, with a median of $298.9 million recorded in 2023.
  • Peak annual rise in Assets Average hit 45.57% in 2024, while the deepest fall reached 25.4% in 2024.
  • Year by year, Assets Average stood at $287.8 million in 2022, then decreased by 24.77% to $216.5 million in 2023, then surged by 45.57% to $315.1 million in 2024, then rose by 15.46% to $363.9 million in 2025.
  • Business Quant data shows Assets Average for PRME at $363.9 million in Q4 2025, $332.0 million in Q3 2025, and $303.6 million in Q2 2025.